Yn ogystal, rydym wedi gweld rhywfaint o welliant mewn perfformiad yn erbyn y targed canser 62-diwrnod. Cynyddodd hyn i 58.6 y cant o gleifion yn dechrau ar eu triniaeth ddiffiniol cyntaf yn ystod y mis o fewn yr amser targed o’i gymharu â’r mis blaenorol.
We have also seen some improvement in performance against the 62-day cancer target which increased compared to the previous month to 58.6 per cent of pathways starting their first definitive treatment in the month within the target time.